+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Analgesics in Estonia

  • PDF Icon

    Report

  • 23 Pages
  • October 2024
  • Region: Estonia
  • Euromonitor International
  • ID: 1572713
Analgesics in Estonia, as a product area, is approaching saturation in 2024, with established brands like ibuprofen and paracetamol continuing to dominate consumer preferences. These products remain indispensable for managing common pain, but the market faces constraints due to a lack of significant innovation. This saturation is reflected in stable yet modest sales growth, with minimal differentiation between products.

The Analgesics in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Market nearing saturation amidst limited innovation
  • Solpadeine's decline following regulatory changes
  • Nycomed SEFA leads in systemic analgesics
PROSPECTS AND OPPORTUNITIES
  • Innovative delivery methods to drive growth
  • Targeting niche markets with specialised pain relief
  • Expansion into natural and herbal alternatives
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2019-2024
  • Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
  • Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
  • Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN ESTONIA
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources